BriaCell Therapeutics Corp.
BCTXLHealthcare|Biotechnology|CA
$0.97
+0.17 (+20.37%)
Tangible Book / Share
$1.77
Cash / Share
$2.36
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.
Upcoming Data Readouts (1)
Dec 2027
Est. completion
P3Breast Cancer
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
NCT06072612n=404